Results 91 to 100 of about 3,671 (210)

Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis

, 2010
Objective. To evaluate the validity of different ASDAS sets to assess disease activity in ankylosing spondylitis (AS) in comparison to standard activity assessment tools in routine clinical setting and to determine the best cut-off values for deciding ...

core  

Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level

Rheumatology and Therapy
Introduction Ixekizumab, an interleukin 17A inhibitor, improved the Assessment of SpondyloArthritis international Society 40 (ASAS40) response rates irrespective of baseline inflammation in international populations with radiographic axial ...
Ning Kong, Jiankang Hu, Dongzhou Liu, Jingyang Li, Huaxiang Wu, Lingyun Sun, Dai Lie, Chunyu Tan, Zhijun Li, Zhengyu Xiao, Cibo Huang, Jian Xu, Yan Yan, Hongying Li, Hejian Zou   +14 more
doaj   +1 more source

HUBUNGAN KADAR FECAL CALPROTECTIN DENGAN DERAJAT AKTIVITAS SPONDILOARTRITIS MENURUT SKOR ASDAS-CRP Penelitian Observasional Analitik Cross Sectional Di poli rawat jalan RSUD Dr. Soetomo Surabaya [PDF]

, 2019
Latar Belakang: Pada hampir separuh pasien SpA didapatkan inflamasi usus mikroskopis subklinis yang berhubungan dengan SpA yang lebih progresif dan sebagian berpotensi berkembang menjadi Crohn's Disease.Fecal Calprotectin merupakan salah satu fecal ...
ASTU ANINDYA JATI, NIM011218026311
core   +1 more source

Which ASDAS cut-off corresponds best to treatment intensification in patients with axial spondyloarthritis in daily practice? A prospective study from a clinical registry

To investigate which Axial Spondyloarthritis Disease Activity Score (ASDAS) cut-off corresponds best with treatment intensification (TI) in daily practice in patients with axial spondyloarthritis (axSpA).
Nezam El-Din, Rabab, Webers, Casper, Vonkeman, Harald E., van Tubergen, Astrid   +3 more
core   +1 more source

Sex-specific disparities in disease activity scores among patients with axial spondyloarthritis and their implications for evaluating the response to tumor necrosis factor alpha inhibitor therapy

Arthritis Research & Therapy
Background We aimed to investigate whether there are sex differences in disease activity measures among patients with axial spondyloarthritis (axSpA) and to determine any potential impact on the assessment of treatment responses to tumor necrosis factor ...
Seulkee Lee, Seonyoung Kang, Hyungjin Kim, Jaejoon Lee, Min-Ji Kim, Hoon-Suk Cha   +5 more
doaj   +1 more source

Evaluation of the presence of neuropathic pain and/or central sensitization in patients with radiographic axial spondyloarthritis followed at a tertiary hospital

Advances in Rheumatology
Background Chronic pain (CP) in radiographic Axial Spondyloarthritis (r-axSpA) is primarily peripheral nociceptive pain. However, many patients experience persistent pain despite treatment, suggesting other underlying mechanisms, such as central ...
Débora de Jesus Sena, Maria Nathalia Gabriela Rocha Pontes de Oliveira, Maria Roberta Melo Pereira Soares, Luís Fábio Barbosa Botelho, Alessandra de Sousa Braz   +4 more
doaj   +1 more source

Asdas responses in patients with axial Spondyloarthritis starting bdmards: results from a multicentre prospective cohort

ASAS and EULAR recommend the use of an improvement ≥1.1 in ASDAS at 12 weeks to determine the continuation of a bDMARD. However, it is debated whether improvements can occur and whether patients’ characteristics influence (time to ...
Santos, M. E., van der Heijde, D., Landewe, R., Ramiro, S.   +3 more
core   +3 more sources

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

, 2010
Background The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess disease activity in ankylosing spondylitis (AS). It fulfils important aspects of truth, feasibility and discrimination.
T. K. Kvien, E. Lie, Machado, Pedro, Kvien, Tore K., Lie, E., Assessment SpondyloArthrit Int Soc, R. Landewe, Braun, J., Baker, D., Braun, Jürgen, Kvien, T.K., Lie, Elisabeth, Machado, P., J. Braun, van der Heijde, Desiree, D. van der Heijde, Landewe, Robert, null null, Heijde, D. van der, Braun, Juergen, Landewe, R., D. Baker, Baker, Daniel, Heijde, D.H.D. van der, P. Machado   +24 more
core   +1 more source

Analysis of inflammatory markers in peripheral blood, ASDAS, BASDAI, SF-36, EQ-5D, EQ-5D VAS and HADS during the 8-week intervention period.

, 2019
Analysis of inflammatory markers in peripheral blood, ASDAS, BASDAI, SF-36, EQ-5D, EQ-5D VAS and HADS during the 8-week intervention period.
M. G. van de Sande (8066585), C. D. Popa (8066594), D. L. P. Baeten (8066600), H. M. Y. De Jong (8066579), M. Kox (8066582), G. A. Buijze (8066576), P. Pickkers (8066597), D. Van Schaardenburg (8066588), R. M. Van Vugt (8066591)   +8 more
core   +1 more source

Psychometric Properties of the Persian Version of the Evaluation of Ankylosing Spondylitis Quality of Life (EASi‐QoL) and Ankylosing Spondylitis Disease Activity Score (ASDAS) Questionnaires: A Cross‐Sectional Study

Health Science Reports
Background and Aims Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects quality of life (QoL) due to its impact on physical and emotional well‐being.
Maryam Hosseini, Amirmasoud Kazemzadeh Houjaghan, Ghazal Behzad, Sahar Ghorbanpour, Seyede Zahra Emami Razavi, Mohaddeseh Azadvari, Shafieh Movaseghi, Negar Salaminour   +7 more
doaj   +1 more source